These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 23964145)

  • 1. Diagnostic accuracy of a new point-of-care screening assay for celiac disease.
    Benkebil F; Combescure C; Anghel SI; Besson Duvanel C; Schäppi MG
    World J Gastroenterol; 2013 Aug; 19(31):5111-7. PubMed ID: 23964145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test.
    Bienvenu F; Anghel SI; Besson Duvanel C; Guillemaud J; Garnier L; Renosi F; Lachaux A; Bienvenu J
    BMC Gastroenterol; 2014 Nov; 14():186. PubMed ID: 25376178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population.
    Bienvenu F; Besson Duvanel C; Seignovert C; Rouzaire P; Lachaux A; Bienvenu J
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1418-23. PubMed ID: 23032795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.
    Tonutti E; Visentini D; Picierno A; Bizzaro N; Villalta D; Tozzoli R; Kodermaz G; Carroccio A; Iacono G; Teresi S; La Chiusa SM; Brusca I
    J Clin Lab Anal; 2009; 23(3):165-71. PubMed ID: 19455636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
    Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
    Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet.
    Nachman F; Sugai E; Vázquez H; González A; Andrenacci P; Niveloni S; Mazure R; Smecuol E; Moreno ML; Hwang HJ; Sánchez MI; Mauriño E; Bai JC
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):473-80. PubMed ID: 21537123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children.
    Frulio G; Polimeno A; Palmieri D; Fumi M; Auricchio R; Piccolo E; Carandente Giarrusso P
    Clin Chim Acta; 2015 Jun; 446():237-40. PubMed ID: 25944768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
    Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
    Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a microsphere-based flow cytometric assay for diagnosis of celiac disease.
    Yiannaki EE; Zintzaras E; Analatos A; Theodoridou C; Dalekos GN; Germenis AE
    J Immunoassay Immunochem; 2004; 25(4):345-57. PubMed ID: 15552589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.
    Aleanzi M; Demonte AM; Esper C; Garcilazo S; Waggener M
    Clin Chem; 2001 Nov; 47(11):2023-8. PubMed ID: 11673371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-deamidated gliadin peptides antibodies and coeliac disease: state of art and analysis of false-positive results from five assays].
    Lutteri L; Sagot C; Chapelle JP
    Ann Biol Clin (Paris); 2010; 68(2):149-56. PubMed ID: 20348047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
    Sayed SK; Imam HM; Mahran AM; Refaiy AM
    Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous detection of IgA and IgG antibodies against tissue transglutaminase: The preferred pre-biopsy test in childhood celiac disease.
    Dahlbom I; Nyberg BI; Berntson L; Hansson T
    Scand J Clin Lab Invest; 2016; 76(3):208-16. PubMed ID: 26924622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study.
    Vécsei E; Steinwendner S; Kogler H; Innerhofer A; Hammer K; Haas OA; Amann G; Chott A; Vogelsang H; Schoenlechner R; Huf W; Vécsei A
    BMC Gastroenterol; 2014 Feb; 14():28. PubMed ID: 24524430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.
    Agardh D; Matthias T; Wusterhausen P; Neidhöfer S; Heller A; Lerner A
    Clin Exp Immunol; 2020 Mar; 199(3):294-302. PubMed ID: 31663117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.
    Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE
    Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
    Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
    Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?
    Bannister EG; Cameron DJ; Ng J; Chow CW; Oliver MR; Alex G; Catto-Smith AG; Heine RG; Webb A; McGrath K; Simpson D; Hardikar W
    Am J Gastroenterol; 2014 Sep; 109(9):1478-83. PubMed ID: 25070050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.